Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 42, Issue 10, Pages 1182-1191
Publisher
Wiley
Online
2015-09-18
DOI
10.1111/apt.13409
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B
- (2015) H. Chi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
- (2015) M.-L. Chang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides
- (2014) V. R. Patwardhan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of Virological Response to Entecavir on the Development of Hepatocellular Carcinoma in Hepatitis B Viral Cirrhotic Patients: Comparison Between Compensated and Decompensated Cirrhosis
- (2014) Soon Sun Kim et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs
- (2014) Hyung Rae Sohn et al. BMC INFECTIOUS DISEASES
- Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
- (2014) Pauline Arends et al. GUT
- Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
- (2013) A. K. Singal et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies
- (2013) Victoria Arama et al. ANTIVIRAL THERAPY
- Impact of Therapy on the Long-Term Outcome of Chronic Hepatitis B
- (2013) Yun-Fan Liaw Clinics in Liver Disease
- Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients
- (2013) Wen-Juei Jeng et al. HEPATOLOGY
- Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
- (2013) Grace Lai-Hung Wong et al. HEPATOLOGY
- Long-term therapy for chronic hepatitis B: Hepatitis B virus DNA suppression leading to cirrhosis reversal
- (2013) Patrick Marcellin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Patient preferences for hepatitis B therapy
- (2012) Seng Gee Lim et al. ANTIVIRAL THERAPY
- Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection
- (2012) C-M Chu et al. BRITISH JOURNAL OF CANCER
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis
- (2012) Takashi Kumada et al. JOURNAL OF HEPATOLOGY
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection
- (2010) Osamu Yokosuka et al. JOURNAL OF HEPATOLOGY
- Some Methods of Propensity-Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations
- (2009) Peter C. Austin BIOMETRICAL JOURNAL
- Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B
- (2009) Yi-Cheng Chen et al. HEPATOLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia
- (2009) Yun-Fan Liaw JOURNAL OF HEPATOLOGY
- Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
- (2008) J. J. Y. SUNG et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Entecavir in Patients With Chronic Hepatitis B and Advanced Hepatic Fibrosis or Cirrhosis
- (2008) Eugene Schiff et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
- (2007) Giovanna Fattovich et al. JOURNAL OF HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started